RLYB - rallybio.com Sales Growth YoY (TTM)

Public company logo of rallybio.com (RLYB)

The annual revenue growth dynamics over a rolling period for Rallybio Corporation (RLYB) are comparable to the base value of its patents and funding. The current value of -35.10 characterizes this valuation parameter. Growth is supported by the development of antibodies for neonatal health and the prevention of fetal pathologies. Process stability is ensured by the air freight of bioccomponents, which eliminates supply chain disruptions during drug development.

RLYB (Rallybio Corp.) Sales Growth YoY (Last Twelve Months) history from 02/11/2024 to 11/18/2026

Rallybio Corp. (RLYB) - metric breakdowns and financial figures

Summary company analytics:RLYB Rallybio
Manufactured product of Rallybio Corp

This indicator captures the percentage change in revenue over a rolling 12-month period, reflecting the pace of business expansion. Professionals utilize the current year-over-year revenue growth rate (TTM) to verify the scalability of commercial operations. A steady upward trend confirms organic growth, whereas sharp peaks signal the risk of overpayment. For Rallybio Corporation (RLYB), this metric is secondary to clinical success. The company's valuation is driven by trial results for rare pathologies, regardless of macroeconomic conditions.

Competitors of Rallybio Corporation (RLYB)

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|Eupraxia Pharmaceuticals - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) BioHarvest Sciences Inc. BHST|EXOZ: Sales Growth YoY (TTM)|Oramed (ORMP) - Sales Growth YoY (TTM)|ENTX (Entera Bio) - Sales Growth YoY (TTM)|ipatherapeutics.com (HYFT) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Trailing Twelve Months Revenue Growth|TELO: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)